Drug Database
CO

collagen (Gelfix / Biopad / Condress)

✓ Approved

Merck & Co. · 治疗药物

什么是 collagen?

collagen 是一种治疗药物,由Merck & Co.研发。该药已获批,用于治疗相关适应症,给药途径:Topical。

药物档案

商品名Gelfix, Biopad, Condress
公司Merck & Co.
给药途径Topical
状态Approved

治疗适应症

collagen 针对 4 个适应症,涉及 3 个治疗领域。

治疗领域疾病/病症分期
General disorders and administration site conditionsImpaired healing✓ Approved
Skin and subcutaneous tissue disordersDiabetic foot✓ Approved
Skin and subcutaneous tissue disordersDecubitus ulcer✓ Approved
Vascular disordersPeripheral venous disease✓ Approved

相关研究文献

PubMedBiomaterials advances2026-11-19

Retraction notice to "Laminin mimetic angiogenic and collagen peptide hydrogel for enhance dermal wound healing" [Biomater. Adv. 158 (2024) 213761].

Saklani Meenakshi M, Jha Chandan B CB, Baidya Anurag T K ATK, Singh Sweta S et al.

PMID 43053508
阅读全文 →
PubMedBDJ open2026-11-19

Biomodifying effect of rutin extracted from Dimorphandra gardneriana on tensile strength and color change of dentin collagen.

Aragão Lara R LR, Freitas Isabely B IB, de Morais Selene M SM, Pinheiro Solange de O SO et al.

To evaluate the effect of rutin extracted from Dimorphandra gardneriana on the tensile strength and color changes of demineralized dentin collagen. Two independent experiments were conducted using 244 sound human third molars. For quantitative color analysis, 204 teeth were used to prepare 204 dentin discs, which were allocated to 12 groups (n = 17). For tensile strength analysis, 40 teeth were used to prepare 120 rectangular dentin specimens, which were allocated to 12 groups (n = 10). Specimens were completely demineralized in 10% phosphoric acid and treated with distilled water (control) or aqueous rutin solutions (0.004%, 0.008%, or 0.0125%) for 1, 30, or 60 min. Color changes (ΔL*, Δa*, Δb*, and ΔE*ab) were assessed spectrophotometrically before and after biomodification, and tensile strength was measured using a universal testing machine. Data were analyzed using two-way ANOVA followed by the Student-Newman-Keuls test when significant effects were detected (α = 0.05). No significant effects of treatment, biomodification time, or their interaction were observed for ΔL*, Δa*, Δb*, or ΔE*ab (p > 0.05). Rutin-treated specimens showed significantly higher tensile strength than control specimens (p < 0.05), whereas no significant differences were observed among the rutin concentrations (p > 0.05). Neither biomodification time nor the treatment × time interaction significantly affected tensile strength (p > 0.05). Within the limitations of this in vitro study, rutin increased the immediate tensile strength of demineralized dentin collagen, whereas no significant differences in color change were observed among the treatments under the conditions evaluated.

PMID 43052264
阅读全文 →
PubMedCell death & disease2026-11-19

Beyond the dimer: functional specialization of MIA/CD-RAP through multimerization.

Staebler Sebastian S, Riechers Alexander A, Damardeh Mahyar M, Mirzaalian Dastjerdi Houman H et al.

The dimerization of the secreted protein MIA/CD-RAP has been linked to melanoma progression, but its multimerization in cartilage has remained unknown. Here, we identify a previously unrecognized multimeric state of MIA/CD-RAP that forms highly stable fibrillar assemblies in human cartilage, distinct from the melanoma-associated dimers. These multimers closely interact with extracellular matrix components, particularly collagen fibers, and are induced by low-molecular-weight cartilage-derived factors, forming supramolecular complexes resistant to denaturation. Using interferometric scattering microscopy (iSCAT) and molecular docking, we identify MIA multimers as well as visualize and model the regulated self-assembly of MIA/CD-RAP. Furthermore, we study these as a function of modulation by newly developed peptides such as AR68 or GL2. Loss of MIA/CD-RAP causes collagen disorganization, cellular vacuolization, abnormal microvilli, and increased tissue stiffness, indicating a structural role in matrix maturation. Pharmacological stabilization of the multimer accelerates osteoarthritis, suggesting the need for constant dynamic multimerization in vivo. Inhibition of multimerization is protective, supporting the idea of differential functions of the defined interaction status of MIA/CD-RAP. Importantly, our findings highlight a broader molecular concept: multimerization can fundamentally alter protein function; thus, not only expression but also conformation and supramolecular organization determine biological roles. Multimeric MIA/CD-RAP exhibits distinct functions compared to its monomeric and dimeric forms, highlighting protein self-assembly as a pivotal regulatory mechanism with far-reaching implications beyond MIA/CD-RAP.

PMID 43052239
阅读全文 →
PubMedCellular and molecular life sciences : CMLS2026-11-19

Targeting the Thy-1 mechanotransduction regulator rescues regenerative wound healing and induces hair follicle neogenesis under high tension.

Zhao Hao-Ran HR, Wang Fu-Chen FC, Yue Jin J, Xue Ling-Fa LF et al.

Mechanical tension is a critical driver of hypertrophic scar (HS) formation, primarily by inducing the differentiation of fibroblasts into pathological myofibroblasts. However, the upstream mechanotransduction regulators that initiate this fibrotic cell fate switch remain poorly understood. This study investigates the role of the glycoprotein Thy-1 (CD90) as a mechanotransduction regulator and its regulation of the p38MAPK signaling pathway under high-tension conditions. We established a murine high-tension scar model to simulate pathological scarring in vivo. Recombinant adeno-associated virus (rAAV) vectors were administered to locally knock down or overexpress Thy-1. Results demonstrated that Thy-1 was significantly upregulated and activated by high tension. Local knockdown of Thy-1 significantly reduced scar area and promoted orderly collagen arrangement. Crucially, Thy-1 silencing shifted the healing process toward functional regeneration, evidenced by the neogenesis of hair follicles and sebaceous glands. Mechanistically, silencing Thy-1 suppressed the downstream pro-fibrotic program, including p38MAPK phosphorylation, transforming growth factor-beta (TGF-β) expression, alpha-smooth muscle actin (α-SMA) levels, and excessive deposition of Collagen I and III. In vitro studies indicated that Thy-1 knockdown enhanced fibroblast proliferation and migration, suggesting its pathological role lies in driving terminal fibrotic differentiation. The Thy-1/p38MAPK axis acts as a crucial mechanotransduction pathway governing fibroblast-to-myofibroblast differentiation. Targeting this axis represents a promising therapeutic strategy to switch cell fate during healing, preventing pathological scarring and promoting functional skin regeneration.

PMID 43052516
阅读全文 →
PubMedJournal of neuroinflammation2026-11-19

Human umbilical cord mesenchymal stem cell-derived exosomes alleviate neurocognitive disorders in chronic obstructive pulmonary disease by suppressing neuroinflammation.

Xiao Hui H, Yu Xiao X, Dong Yiding Y, Bao Shilong S et al.

Patients with chronic obstructive pulmonary disease (COPD) frequently suffer from COPD-related neurocognitive disorders (COPD-NCDs), which severely impair their quality of life. Neuroinflammation is a key pathological mechanism, but effective therapies are still lacking. Human umbilical cord mesenchymal stem cell-derived exosomes (hUCMSC-Exos) have anti-inflammatory and neuroprotective effects in other neurological disorders. However, their efficacy and underlying mechanisms in COPD-NCDs remain unclear. Female BALB/c mice were divided into normal control (NC), COPD-NCDs (model), COPD-NCDs + PBS (vehicle), and COPD-NCDs + Exos (treatment) groups. COPD-NCDs was induced by 24 weeks of cigarette smoke exposure, and hUCMSC-Exos were administered via tail-vein during weeks 20-23. Pulmonary function, cognitive function, lung and hippocampal pathology, microglial activation, inflammatory cytokines, astrocytic A1/A2 phenotype, and brain RNA-seq were assessed. hUCMSC-Exos significantly improved lung function in COPD-NCDs mice and alleviated pulmonary inflammation, emphysema, collagen deposition, and systemic inflammation. Importantly, hUCMSC-Exos also ameliorated cognitive impairment in COPD-NCDs mice, alleviated hippocampal neuronal damage (increased Nissl-positive neurons and NeuN expression), suppressed microglial activation, and reduced the levels of inflammatory cytokines in brain tissue. Furthermore, hUCMSC-Exos downregulated C3, a marker of type A1 neurotoxic astrocytes, and upregulated S100A10, a marker of type A2 neuroprotective astrocytes, in the hippocampus of COPD-NCDs mice. RNA-seq suggested modulation of MAPK, Wnt, cAMP and PI3K-Akt signaling pathways. hUCMSC-Exos ameliorated cognitive impairment in COPD-NCDs mice, which may be associated with the suppression of microglial activation and the shift in astrocyte phenotype from A1-like to A2-like. These findings highlight the potential of hUCMSC-Exos as a therapeutic strategy for COPD-NCDs, although the causal relationship between the phenotypic shift and cognitive improvement requires further mechanistic validation.

PMID 43053036
阅读全文 →
PubMedLasers in medical science2026-11-19

Er: YAG laser for lip and perioral remodelling with emphasis on SMOOTH® mode: a systematic review of clinical evidence.

Giovannacci Ilaria I, Iaria Roberta R, Maffei Renzo R, Antonelli Rita R et al.

This review aimed to assess the current evidence on the use of Er: YAG laser for non-injective lip and perioral aesthetic remodelling, with emphasis on SMOOTH® mode and to determine whether the reported treatment outcomes reflect true lip-volume augmentation or perceived fullness resulting from tissue remodelling. A systematic literature search was conducted in MEDLINE/PubMed, Web of Science, Scopus, and the Cochrane Library, with no date restrictions. Studies were eligible if they reported clinical outcomes after 2940-nm Er:YAG laser treatment relevant to the lips, labial mucosa, perioral region, nasolabial folds, or anatomically related areas. Risk of bias was assessed using RoB 2 for randomized or split-face randomized studies and ROBINS-I for non-randomized prospective studies. Five studies involving 80 participants across mixed facial cohorts were included; only a subset received labial or isolated perioral treatment. Two studies were classified as Level 2b evidence and two as Level 4 evidence. No study measured objective lip volume, vermilion height, lip projection, Cupid's bow definition or validated lip-specific fullness outcomes. One study measured upper-lip morphology with three-dimensional stereophotogrammetry, reporting shortening of the philtral length and a decreased nasolabial angle, but did not quantify lip volume. Evidence was more consistent for perioral rejuvenation, nasolabial fold remodelling, rhytid reduction, dermal thickening, skin texture improvement, and collagen remodelling. Reported adverse events were generally transient, although post-inflammatory hyperpigmentation and labial herpes simplex reactivation were clinically relevant safety considerations. Current evidence supports Er:YAG laser as a biologically plausible and clinically promising modality for perioral rejuvenation and tissue-quality improvement. However the five eligible studies were heterogeneous, drew on mixed facial cohorts, and only one of them assessed the labial unit directly, measuring upper-lip morphology rather than volumeThe evidence is therefore insufficient to demonstrate true objective lip-volume augmentation - though this does not mean such augmentation does not occur. Er:YAG laser should be described as a non-injective remodelling approach that may enhance perceived fullness through tissue remodelling, rather than as a proven volumetric substitute for injectable fillers, and its effects should not be extrapolated between modalities.

PMID 43052576
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多collagen